Mohammed M Alanazi Selected Research

Mohammed M Alanazi Research Topics

Disease

17	Neoplasms (Cancer) 08/2023 - 01/2019
7	Inflammation (Inflammations) 09/2023 - 08/2021
3	Alzheimer Disease (Alzheimer's Disease) 07/2023 - 01/2022
2	Memory Disorders (Memory Loss) 04/2024 - 07/2023
2	Dementia (Dementias) 04/2024 - 07/2023
2	Ulcer 11/2023 - 08/2023
2	Diabetes Mellitus 06/2023 - 05/2023
2	Breast Neoplasms (Breast Cancer) 06/2023 - 06/2019
2	Hepatocellular Carcinoma (Hepatoma) 03/2023 - 01/2020
2	Experimental Arthritis 07/2022 - 01/2020
2	Acute Lung Injury 06/2022 - 01/2022
2	Autistic Disorder (Autism) 05/2022 - 01/2022
1	Infections 01/2024
1	Cognitive Dysfunction 12/2023
1	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2023
1	Tremor (Tremors) 12/2023
1	Cholangiocarcinoma 11/2023
1	Stomach Ulcer (Gastric Ulcer) 11/2023
1	Hemorrhage 11/2023
1	Wounds and Injuries (Trauma) 10/2023
1	Colitis 10/2023
1	Ulcerative Colitis 10/2023
1	Epilepsy (Aura) 09/2023
1	Diabetic Neuropathies (Diabetic Neuropathy) 08/2023
1	Weight Loss (Weight Reduction) 07/2023
1	Virus Diseases (Viral Diseases) 06/2023
1	Colorectal Neoplasms (Colorectal Cancer) 06/2023
1	Fibrosis (Cirrhosis) 06/2023
1	Hyperlipidemias (Hyperlipidemia) 06/2023
1	Insulin Resistance 06/2023
1	Non-alcoholic Fatty Liver Disease 06/2023
1	Adenocarcinoma of Lung 05/2023
1	Lung Neoplasms (Lung Cancer) 05/2023

Drug/Important Bio-Agent (IBA)

7	AntioxidantsIBA 11/2023 - 01/2021
6	CytokinesIBA 10/2023 - 03/2019
5	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 08/2022 - 06/2019
4	Transcription Factors (Transcription Factor)IBA 04/2023 - 06/2020
3	Doxorubicin (Adriamycin)FDA LinkGeneric 07/2023 - 08/2021
3	Protein Kinases (Protein Kinase)IBA 07/2023 - 03/2023
3	Phosphotransferases (Kinase)IBA 07/2023 - 06/2019
3	Chemokine ReceptorsIBA 04/2023 - 01/2020
2	Streptozocin (Streptozotocin)FDA Link 04/2024 - 07/2023
2	Aripiprazole (Abilify)FDA Link 04/2024 - 07/2023
2	AcetylcholinesteraseIBA 07/2023 - 01/2022
2	Blood Glucose (Blood Sugar)IBA 06/2023 - 05/2023
2	Insulin (Novolin)FDA Link 06/2023 - 01/2021
2	Antineoplastic Agents (Antineoplastics)IBA 03/2023 - 12/2021
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2023 - 08/2021
2	apremilastIBA 06/2022 - 01/2022
2	Acetazolamide (Diamox)FDA LinkGeneric 11/2019 - 01/2019
2	Protein Isoforms (Isoforms)IBA 11/2019 - 01/2019
1	Peptides (Polypeptides)IBA 01/2024
1	ChitosanIBA 01/2024
1	Cadmium Chloride (Cadmium Dichloride)IBA 12/2023
1	Protein Kinase InhibitorsIBA 11/2023
1	infigratinibIBA 11/2023
1	Ethanol (Ethyl Alcohol)IBA 11/2023
1	Hemostatics (Antihemorrhagics)IBA 10/2023
1	CollagenIBA 10/2023
1	HydrogelsIBA 10/2023
1	Hydroxyproline (4 Hydroxyproline)IBA 10/2023
1	Acetic Acid (Vinegar)FDA LinkGeneric 10/2023
1	Pentylenetetrazole (Metrazol)IBA 09/2023
1	Oxidants (Oxidizing Agents)IBA 09/2023
1	ChemokinesIBA 09/2023
1	Thioredoxin-Disulfide ReductaseIBA 09/2023
1	DNA (Deoxyribonucleic Acid)IBA 08/2023
1	AlloxanIBA 08/2023
1	chrysinIBA 08/2023
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 08/2023
1	Biomarkers (Surrogate Marker)IBA 08/2023
1	4-hydroxyquinazolineIBA 07/2023
1	Dopamine (Intropin)FDA LinkGeneric 07/2023
1	SolutionsIBA 07/2023
1	Schiff Bases (Schiff Base)IBA 07/2023
1	coumarinIBA 07/2023
1	Amylases FDA Link 06/2023
1	TriazolesIBA 06/2023
1	GlucosidasesIBA 06/2023
1	HydrazonesIBA 06/2023
1	Hypoglycemic Agents (Hypoglycemics)IBA 06/2023
1	BenzoxazolesIBA 06/2023
1	OxadiazolesIBA 06/2023
1	NucleosidesIBA 06/2023
1	antineoplaston A10 (A 10)IBA 06/2023
1	Dihydrotachysterol (AT 10)IBA 06/2023
1	CholesterolIBA 06/2023
1	NF-kappa B (NF-kB)IBA 06/2023
1	betulinIBA 06/2023
1	Terpenes (Terpenoids)IBA 06/2023
1	LipidsIBA 06/2023
1	Sirtuin 1IBA 06/2023
1	Triglycerides (Triacylglycerol)IBA 06/2023
1	PAMAM StarburstIBA 05/2023
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 05/2023

Therapy/Procedure

9	Therapeutics 08/2023 - 06/2019
3	Drug Therapy (Chemotherapy) 08/2023 - 03/2023
1	Ligation 11/2023
1	Debridement 10/2023
1	Molecular Targeted Therapy 08/2023